Microbiota-derived metabolites in inflammatory bowel disease

Seminars in Immunopathology · Published 2025-03-03 · DOI 10.1007/s00281-025-01046-9

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s00281-025-01046-9

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Macrophage-driven inflammation in inflammatory bowel disease: mechanisms and therapeutic opportunities · Frontiers in Bioengineering and Biotechnology · 2026 · Cites or is cited by this article
• Resetting immunometabolic set points in autoimmune disease · Journal of Translational Autoimmunity · 2026 · Cites or is cited by this article
• Advances in manufacturing chimeric antigen receptor immune cell therapies · Seminars in Immunopathology · 2024 · Same journal
• Mechanistic insights into intrauterine adhesions · Seminars in Immunopathology · 2024 · Same journal
• The when, what, and where of naturally-acquired microchimerism · Seminars in Immunopathology · 2025 · Same journal
• Metabolic Regulation in the Induction of Trained Immunity · Seminars in Immunopathology · 2024 · Same journal
• The sweet and the bitter sides of galectin-1 in immunity: its role in immune cell functions, apoptosis, and immunotherapies for cancer with a focus on T cells · Seminars in Immunopathology · 2025 · Same journal
• Early-life risk factors which govern pro-allergic immunity · Seminars in Immunopathology · 2024 · Same journal
• Micro-to multi-chimerism: the multiple facets of a singular phenomenon · Seminars in Immunopathology · 2025 · Same journal
• Butyrate remodels the immune-epigenetic-gut-lung axis: Emerging mechanisms and therapeutic perspectives in asthma · Seminars in Immunopathology · 2026 · Same journal